College Council 2017 - 2018

Prof Pierce K.H Chow
Professor, DukeNUS Medical School, Singapore
Senior Consultant Surgeon, National Cancer Center Singapore
Senior Consultant Surgeon, Singapore General Hospital

(College of Surgeons)


Pierce Chow is Co-Director (Surgical) of the Comprehensive Liver Cancer Clinic at the National Cancer Centre Singapore and Senior Consultant Surgeon in HPB and Transplant Surgery at the Singapore General Hospital. He is concurrently Professor and Course Director at the DukeNUS Medical School Singapore, NMRC Senior-Clinician Scientist and Adjunct Faculty at the Genome Institute of Singapore.


Professor Chow was the Chapter of Surgeon’s Gold Medallist at the conjoint Royal College of Surgeons of Edinburgh/M.Med examination in 1994 and was recipient of the Young Surgeon’s Award of the Academy of Medicine for his research on liver regeneration in 1995.


Professor Chow completed a fellowship in Liver Transplantation in Australia and leads multi-disciplinary translational research on the genomic heterogeneity of hepatocellular carcinoma. In 1998 He co-founded the Asia-Pacific Hepatocellular Carcinoma Trials Group and has been the protocol chair of 5 multi-national prospective clinical trials. In 2012 the National Medical Research Council Singapore conferred upon him the National Outstanding Clinician-Scientist Award for his research on Liver Cancer.


Professor Chow was awarded the NMRC Translational-Clinical Research Grant for the Flagship Program in Liver Cancer in 2016.  He is the inaugural President of the College of Clinician-Scientist.

Vice President

Prof Aung Tin

Executive Director, Singapore Eye Research Institute
Deputy Medical Director (Research), Singapore National Eye Centre
Senior Consultant and Head, Glaucoma Dept, Singapore National Eye Centre
Vice Chair (Research), Ophthalmology and Visual Sciences ACP
Professor, Dept of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore and Duke-NUS

(College of Ophthalmologists)


After receiving his MBBS and Master of Medicine in Ophthalmology from the National University of Singapore, Prof Aung obtained the Fellowships of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists in 1997. He completed a glaucoma fellowship in the Singapore National Eye Centre in 1999-2000, and from 2000-2003, he was trained at Moorfields Eye Hospital in London and the Institute of Ophthalmology, University College London. In 2003, Prof Aung was awarded a PhD in Molecular Genetics from University College London, UK.

Prof Aung is currently the Executive Director of Singapore Eye Research Institute. As a clinician-scientist, he also leads the Glaucoma Research Group at SNEC/Singapore Eye Research Institute (SERI). His main research interests are angle closure glaucoma (ACG) and the molecular genetics of eye diseases. Prof Aung is very active in clinical glaucoma research and has conducted many studies on therapeutics, imaging, screening, clinical course and surgical outcomes of glaucoma. He has completed several randomized controlled trials on laser and surgical treatment of ACG, and is currently leading a multicentre trial in Asia on surgical management of glaucoma. For his research in genetics, Prof Aung set up multicenter international consortia on glaucoma genetics encompassing the 3 major forms of the disease (ACG, open angle glaucoma and exfoliation syndrome).

With more than 450 publications, he has been an invited lecturer to more than 150 international conferences and has received numerous awards including the SingHealth Excellence Distinguished Visionary Leader Award Awards , NUS University Outstanding Researcher Award,  ARVO Fellow (Silver Award), STAR Investigator Award, NMRC Clinician Scientist Award, the President’s Science and Technology Award, SingHealth GCEO Excellence Award, the De Campo and Nakajima Award from the Asia Pacific Academy of Ophthalmology, as well as the Alcon Research Institute Award. Prof Aung has been awarded more than US$20 million in competitive research grant funding and is a member of the Editorial Boards of Ophthalmology, Journal of Glaucoma, Eye, Graefe’s Archive for Clinical and Experimental Ophthalmology and 6 other journals.


Prof Aung is a member of the Editorial Boards of Ophthalmology, Journal of Glaucoma, Eye, Graefe’s Archive for Clinical and Experimental Ophthalmology, and 6 other journals. He is the current President of the World Glaucoma Association and a Board member of Asia Pacific Glaucoma Society and Asian Angle Closure Glaucoma Club. In Singapore, he is a past President of both the College of Ophthalmologists of Singapore and the Singapore Society of Ophthalmology. He is also the Academic Vice Chair (Research) of the Academic Clinical Program for Ophthalmology in SingHealth / Duke-NUS Graduate School of Medicine.

Honorary Secretary

A/Prof Lynette Shek

Head and Senior Consultant, Division of Paediatric Allergy, Immunology & Rheumatology

(College of Paediatrics and Child Health)

A/Prof Lynette Shek is currently Head and Senior Consultant of the Division of Paediatric Allergy, Immunology and Rheumatology at the National University Hospital. She obtained her basic medical degree from the National University of Singapore with honours in 1994, and received her paediatric training at the National University Hospital from 1996 to 2001. She attained her postgraduate paediatric degree in 1997. She was accredited as a paediatric specialist by the Ministry of Health, Singapore in 2001 and became a Fellow of the Academy of Medicine, Singapore in 2004. She has been a member of the Faculty of Medicine, Department of Paediatrics since 1996, and was promoted to Associate Professor in 2007. She is also visiting consultant in Paediatric Rheumatology at KK Women's and Children's Hospital, Singapore. Her specialist training in allergy was undertaken from 2002 to 2003 at Mt Sinai School of Medicine, New York. There, she trained under Prof Hugh Sampson, a world-renowned expert in the field of allergy. She also spent some time under the tutelage of Prof Thomas Lehman, Chief, Division of Paediatric Rheumatology, at the Hospital for Special Surgery, New York. Since her return in 2004, she has practised as a paediatrician in NUH. Her clinical practice involves all areas of general paediatrics, with special interests in the fields of allergy, immunodeficiency and rheumatology. She sees the adult patients with allergy and immunodeficiency in NUH as well. She is a fellow of the American Academy of Allergy, Asthma and Immunology. She is also actively involved in research, and is a member of both the Asthma & Allergy Research Programme and the Human & Molecular Research Programme at the National University of Singapore. She has published her work on allergy and rheumatology in numerous medical journals. Among the awards she has received is the President's Scholarship to study medicine in NUS. She also received numerous undergraduate awards for being first in her medical school class 3 years in a row. She won the NUH Young Doctor's Award in 1999 for her research on the genetics of asthma and atopy in local Chinese Children. She was the youngest recipient of the NMRC-BMRC Clinician Scientist Investigator Award in 2005. In 2011, she won the Clinician Scientist (Investigator) Award for her work in early childhood rhinitis at the National Medical Research Council (NMRC) Awards Ceremony.

Honorary Treasurer













A/Prof Mahesh Choolani
Associate Professor and Research Director, Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore
Senior Consultant, Department of Obstetrics & Gynaecology, National University Health System

(College of Obstetricians and Gynaecologists)

A/Professor Choolani is a Clinician-Scientist, and currently holds the NMRC Senior Clinician Scientist Award. He was the founding Chairman of the NUS Clinician-Scientist Unit, and the National Healthcare Group Clinician Leadership in Research Programme. He is a current Board Member of the Singapore College of O&G.

Council Members

A/Prof David Lye Chien Boon
Senior consultant, Institute of Infectious Diseases and Epidemiology (IIDE), Tan Tock Seng Hospital
Yong Loo Lin School of Medicine, National University of Singapore
Lee Kong Chian School of Medicine, Nanyang Technological University
Principal investigator, Singapore Infectious Disease Clinical Research Network (SCRN)

(College of Physicians)

Professor Lye was a co-principal investigator in STOP-dengue translational clinical research programme (2008-2014) which focused on the control, treatment and prevention of adult dengue. Highlights from clinical research in STOP-dengue included a large retrospective cohort of adult dengue from 2005 to 2008 (“ARDENT”) and a prospective adult dengue study (PADS) from 2010 to 2012, which have provided a lot of insights into the management of adult dengue especially among the elderly. A randomised clinical trial of prophylactic platelet transfusion for adult dengue patients with thrombocytopenia (ADEPT) was completed.

As the lead for SCRN, Professor Lye is involved in randomised clinical trials to optimise antibiotic use in the era of antibiotic resistance. A-KLASS is a clinical trial of oral versus intravenous antibiotics to treat Klebsiella liver abscess. MERINO and MERINO-2 are two clinical trials studying carbapenem-sparing therapy for E coli and K pneumoniae bacteraemia with extended spectrum beta-lactamases, and gram negative bacteraemia with chromosomal AmpC producers respectively, in collaboration with Australasian Society for Infectious Diseases Clinical Research Network (ASID CRN). Funded via Late Phase Clinical Trial Grant, CAMERA-2 is a clinical trial in collaboration with ASID CRN on better ways of treating methicillin-resistant S aureus bacteraemia.


A/Prof Narayanan Gopalakrishna Iyer
Head and Senior Consultant
SingHealth Duke-NUS Head & Neck Centre
National Cancer Centre Singapore
MBBS (Hons), PhD (Cambridge), FRCSEd, FAMS

(College of Surgeons)

Dr Gopal Iyer graduated top of his medical school class at NUS in 1998, with Honours. He subsequently went on to complete a PhD in molecular carcinogenesis at the University of Cambridge. He trained as a General surgeon at Singapore General Hospital and then went on to two separate head and neck surgical fellowships at Sydney Head and Neck Cancer Institute at Royal Prince Alfred Hospital, Australia and Memorial Sloan-Kettering Cancer Centre, New York, USA. At the end of his fellowship at MSKCC, he was awarded the Michael Burt award for being the best fellow in the surgical division both in terms of operative skill and research output.

Dr Iyer is Head of the SingHealth Duke-NUS Head and Neck Centre and head and neck surgeon in National Cancer Centre and Singapore General Hospital. He has extensive experience in the surgical management of head and neck cancers, as well as surgery for benign diseases in the head and neck (including thyroid, salivary gland and skin lesions). He performs complex resections and reconstructions of cancers involving the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, paranasal sinuses and neck. He is involved in the robotic and endoscopic head and neck surgical program having performed a number of these procedures locally and mentored the first ever robotic thyroidectomy in Australia in Feb 2012. He is actively involved in research and leads a number of research programs that aim to determine prognostic factors in oral cancers, identifying the cause of head and neck cancers in young people and development of novel therapeutic strategies in treating these cancers.


Assistant Prof Iain Tan

Consultant, Division of Medical Oncology, National Cancer Centre Singapore
Clinician Scientist, Genome Institute of Singapore, A-STAR
Assistant Professor, Duke-NUS Medical School, National University of Singapore
Adjunct Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore

Dr. Iain Tan is a Consultant GI Medical Oncologist, leading the colorectal cancer service in the Department  of  Medical  Oncology,  National  Cancer  Centre,  Singapore. He co-chairs  the centre’s multidisciplinary  tumor  board  and  GI  cancer  Comprehensive  Research  Program.  Concurrently,  he  runs  a  translational  laboratory  as  a  clinician  scientist  at  the  Genome Institute of Singapore and is an Assistant Professor at Duke-NUS Graduate Medical School.

His  research  focuses  on  non-invasive  diagnostics,  understanding  and  intervening  in  the metastatic  cascade  and  neo-antigen  based  immunotherapy.    He  is  a  key member  of Singapore’s POLARIS  program  developing  clinical  grade  molecular  assays  to  direct  patient management.  He  has  published  widely  in  leading  journals  including Journal  of  Clinical Oncology,  Gastroenterology,  Nature  Genetics, Nature  Medicine  and  Science  Translational Medicine.

His  research  achievements  have  been  recognized  with  an  ASCO  Young  Investigator  Award (2010),  an  ASCO  Merit  Award  (2011).  In  2014,  he  received  the  Singapore  Youth  Award (2014), the Country’s highest award for Youth.


Co-Opted Members

Adj A/Prof John Whay-Kuang Chia

MBBS (Singapore), MRCP (UK)
FAMS (Medical Oncology)

Dr John WK Chia is Consultant Medical Oncologist at Oncocare Cancer Centre, and Visiting Consultant at the NCC Singapore. Graduating from the National University of Singapore in 1999, he later obtained his Membership of the Royal College of Physicians in Edinburgh in 2002.  Upon completing his Oncology Boards, he underwent fellowship training in “Immunotherapy for Solid Tumors” - with Prof Malcom Brenner at the Centre for Cell and Gene Therapy, Baylor College, Houston, for the development of cancer vaccines and adoptive T-cell therapy in 2008-2009, and undertook a second clinical fellowship in with Prof Stan Kaye at The Royal Marsden Hospital London from 2011 to 2012 for the advanced management of Gynecological cancers.


Dr Chia is active in clinical trial research; and holds more than 10 million dollars in grant funding, locally and internationally.  He has developed and leads numerous clinical trials in the field of immune check-point inhibitors, cancer vaccines, adoptive T cell therapy, and small molecule targeted therapies for advanced stage cancer.  He co-leads a large randomized clinical trial evaluating Aspirin for colorectal cancer, and is a member of the independent Scientific board for the International Aspirin Foundation